Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

OCU400

product2 mentionslast seen Nov 10, 2026

Novel modifier gene therapy for retinitis pigmentosa.

Relationships 4

Relationship

Roots Pharmaceutical Company WLLcommercializesOCU400

95% confidence1 supporting mentionsfrom Oct 13, 2026

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGAROct 15, 2026Ocugen, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Roots was granted an exclusive, non-sublicensable, royalty-bearing license to make, have made, manufacture, import, export, distribute, use, have used, keep, sell, have sold, or offer for sale, including to research, develop, commercialize, register, modify, enhance, improve, or otherwise exploit OCU400